Zeus Capital Upgrade forecast for Allergy Therapeutics Plc

Allergy Therapeutics Plc (LON:AGY) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary explains whats driven growth in the 6 months to Dec 31st, affects on the full year and what other things should we be focusing on for Allergy Therapeutics. Allergy […]

See More...

Elegant Hotels Group Plc Very attractive long term investment

Elegant Hotels Group Plc (LON:EHG) is the topic of discussion with Mike Allen, head of research at Zeus Capital. Mike explains his take on the 2016 results, talks about key drivers, forecasts and his valuation on the company.┬áCEO Sunil Chatrani talks to DirectorsTalk in the second video about its management contract strategy, the rationale, Waves […]

See More...